Smith & Nephew buys Osiris in regenerative medicine pushMedical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics Share XSmith & Nephew buys Osiris in regenerative medicine pushhttps://pharmaphorum.com/news/smith-nephew-buys-osiris-regenerative-medicine/
